Disclosed herein are anti-IL-7Ra antibodies and antigen-binding fragments, polynucleotides encoding the antibodies and antigen-binding fragments, and pharmaceutical compositions comprising the antibodies and antigen-binding fragments. Medical uses of the anti-IL-7Ra antibodies and antigen-binding fragments described herein are also disclosed.